BamSEC and AlphaSense Join Forces
Learn More

Microbot Medical Inc.

NASDAQ: MBOT    
Share price (11/22/24): $0.98    
Market cap (11/22/24): $16.6 million

Material Contracts Filter

EX-10.1
from 8-K 7 pages Reference Is Made to the at the Market Offering Agreement, Dated as of June 10, 2021 (The “Atm Agreement”), Between Microbot Medical Inc. (The “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”). This Letter (The “Amendment”) Constitutes an Agreement Between the Company and Wainwright to Amend the Atm Agreement as Set Forth Herein. Defined Terms That Are Used but Not Defined Herein Shall Have the Meanings Ascribed to Such Terms in the Atm Agreement. 1. the Defined Term “Agreement” in the Atm Agreement Is Amended to Mean the Atm Agreement as Amended by This Amendment. 2. the Defined Term “Registration Statement” in the Atm Agreement Is Amended by Deleting “333-250966” and Inserting in Its Place “333-275634”. 3. the First Sentence of Section 2(b)(vii) of the Atm Agreement Is Hereby Amended and Restated in Its Entirety as Follows
12/34/56
EX-10.1
from 8-K 41 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 20 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 11 pages Settlement Agreement and Release
12/34/56
EX-10.32
from S-1/A 10 pages Holder of Preferred Investment Options Issued in October 2022 and June 2023 Re: Inducement Offer to Exercise Preferred Investment Options Issued in October 2022 and June 2023 Dear Holder
12/34/56
EX-10.1
from 8-K 10 pages Holder of Preferred Investment Options Issued in October 2022 and June 2023 Re: Inducement Offer to Exercise Preferred Investment Options Issued in October 2022 and June 2023 Dear Holder
12/34/56
EX-10.1
from 8-K 11 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 40 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 40 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 3 pages Re: Amendment to Existing Preferred Investment Options Dear Holder: Reference Is Hereby Made to the Registered Offering on or About the Date Hereof (The “Offering”) by Microbot Medical Inc. (The “Company”) of Its Common Stock, Par Value $0.01 Per Share (“Common Stock”), and/or Other Securities of the Company (Collectively, the “Securities”)
12/34/56
EX-10.1
from 8-K 36 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 35 pages Securities Purchase Agreement
12/34/56
EX-10.4
from 8-K 2 pages Addendum to Employment Agreement Made and Entered Into as of May 15, 2023 by and Between
12/34/56
EX-10.3
from 8-K 2 pages Addendum to Employment Agreement Made and Entered Into as of May 15, 2023 by and Between
12/34/56
EX-10.2
from 8-K 2 pages Addendum to Employment Agreement Made and Entered Into as of May 15, 2023 by and Between
12/34/56
EX-10.1
from 8-K 2 pages Addendum to Employment Agreement Made and Entered Into as of May 15, 2023 by and Between
12/34/56
EX-10.21
from 10-K 2 pages Microbot Medical Ltd. 6 Hayozma St, Yokneam, 2069204. Israel, P.B 242, Tel: 972-4-8200710, Fax: 972-4-8200712 WWW.MICROBOTMEDICAL.com
12/34/56
EX-10.1
from 8-K 43 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 15 pages Asset Purchase Agreement
12/34/56
EX-10.1
from 8-K 15 pages 1. Position and Scope of Position and Working Hours
12/34/56